Related Experiment Videos
Persistent Müllerian structures in a genotypic male
Abstract:
A case report of a male with persistent Müllerian structures is presented. The patient was 34 yr old and had a left inguinal hernia, bilateral cryptorchidism and azoospermia. His karyotype was 46 XY. At operation a uterus with vestigial Fallopian tubes and a hypoplastic testis were found inside the hernial sac. Histological studies confirmed the persistence of Müllerian structures. The clinical implications of anti-Müllerian hormone dysfunction are discussed.
Insights
This case report details a 34-year-old male with persistent Müllerian structures, including a uterus and Fallopian tubes, alongside cryptorchidism and azoospermia. Anti-Müllerian hormone dysfunction is implicated in this rare condition.
Area of Science:
- Reproductive Endocrinology
- Human Genetics
- Surgical Case Reports
Background:
- Persistent Müllerian structures (PMS) is a rare disorder of sex development.
- It is characterized by the presence of Müllerian duct derivatives (uterus, fallopian tubes, and vagina) in a phenotypic male with a 46,XY karyotype.
- PMS is typically caused by mutations in the anti-Müllerian hormone (AMH) gene or its receptor.
Observation:
- A 34-year-old male presented with left inguinal hernia, bilateral cryptorchidism, and azoospermia.
- Surgical exploration revealed a uterus with rudimentary fallopian tubes and a hypoplastic testis within the hernial sac.
- Histological examination confirmed the presence of Müllerian duct remnants.
Findings:
- The patient's karyotype was confirmed as 46,XY.
- Histological analysis verified the persistence of Müllerian structures in the male patient.
- The findings are consistent with a diagnosis of Persistent Müllerian Structures, Type I (male internal pseudohermaphroditism).
Implications:
- This case highlights the importance of considering PMS in males presenting with cryptorchidism, hernias, and infertility.
- Understanding the role of anti-Müllerian hormone is crucial for diagnosing and managing disorders of sex development.
- Further research into AMH signaling pathways may offer therapeutic targets for reproductive dysfunction.